Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole Phase 3 Trial in Japan
jRCT2080225368Phase 3Completed
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of crisaborole in cutaneous reaction and pruritus (2 arms). Started Aug 2020; status: completed.
02
Drugs
crisaborole
03
Conditions
cutaneous reactionpruritus
Beyond the preview
Go deeper on jRCT2080225368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225368.